Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tailored Antiplatelet Therapy Following PCI (TAILOR-PCI)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Mayo Clinic
Spartan Bioscience Inc.
Applied Health Research Centre
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Naveen L. Pereira, Mayo Clinic Identifier:
First received: December 3, 2012
Last updated: June 17, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2020
  Estimated Primary Completion Date: September 2019 (Final data collection date for primary outcome measure)